Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

818.02
-21.9400-2.61%
Pre-market: 822.204.18+0.51%07:20 EDT
Volume:3.33M
Turnover:2.74B
Market Cap:775.47B
PE:69.86
High:843.91
Open:841.51
Low:807.00
Close:839.96
Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, Plug Power, Snap-On

Reuters
·
17 Apr

BRIEF-Bighat Biosciences And Lilly Collaborate To Advance Ai-Driven Antibody Therapeutics

Reuters
·
17 Apr

Bighat Biosciences and Lilly Collaborate to Advance AI-Driven Antibody Therapeutics

THOMSON REUTERS
·
17 Apr

Lilly's Weight-Loss Pill Shocks Wall Street

GuruFocus.com
·
17 Apr

BUZZ-Eli Lilly jumps as pill leads to 7.9% weight loss in late-stage trial

Reuters
·
17 Apr

Top Premarket Gainers

MT Newswires Live
·
17 Apr

BMO Capital Adjusts Eli Lilly Price Target to $900 From $1,010, Maintains Outperform Rating

MT Newswires Live
·
17 Apr

Morning Brew: Eli Lilly's Diabetes Drug Success Sends Shares Soaring

GuruFocus
·
17 Apr

Why Eli Lilly and Company (LLY) Is Among the Best Blue Chip Stocks to Buy According to Billionaires

Insider Monkey
·
17 Apr

Eli Lilly's stock soars as successful trial of weight-loss pill is a game changer

Dow Jones
·
17 Apr

Eli Lilly shares jump 12% on positive Phase 3 results for oral diabetes drug

Investing.com
·
17 Apr

Eli Lilly Shares Jump Premarket After First Pill for Diabetes, Weight Loss Shows Positive Study Results

Dow Jones
·
17 Apr

Palatin Technologies Inc - Phase 2 Trial Showed Significant Weight Loss With Bremelanotide and Tirzepatide

THOMSON REUTERS
·
17 Apr

Palatin Technologies Inc - Ind Filings Expected by End of Q4 2025

THOMSON REUTERS
·
17 Apr

Palatin Technologies Inc - Low-Dose Bremelanotide Prevented Appetite Rebound After Tirzepatide Cessation

THOMSON REUTERS
·
17 Apr

Eli Lilly Stock Soars. Why a Weight-Loss Pill Trial Is Giving It a Boost. -- Barrons.com

Dow Jones
·
17 Apr

BUZZ-Diabetes device makers fall after data on Lilly's weight loss pill

Reuters
·
17 Apr

Stock Track | Eli Lilly Soars 11.99% Pre-Market on Positive Phase 3 Results for Oral Diabetes and Weight Loss Pill

Stock Track
·
17 Apr

Eli Lilly's Stock Soars 13% After Reporting Positive Data From Trial Of Diabetes And Weight-Loss Pill -- MarketWatch

Dow Jones
·
17 Apr

Eli Lilly's stock soars 13% after reporting positive data from trial of diabetes and weight-loss pill

Dow Jones
·
17 Apr